Exhibit 107

Calculation of Filing Fee Tables

Post-Effective Amendment No. 2 to Form F-1

(Form Type)

Addex Therapeutics Ltd.

(Exact Name of Registrant as Specified in Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to Be Paid

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Fees Previously Paid

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Carry Forward Securities

Carry Forward Securities

Equity

Shares, nominal value CHF 1 per share (1)

457(c)

9,230,772

$

1.24

(2)

$

11,446,157.28

0.0000927

1,061.06

F-1

333-262050

January 18, 2022

$

1,418.10

Total Offering Amounts

0.0000927

$

1,061.06

Total Fees Previously Paid

$

1,418.10

Total Fee Offsets

$

-

Net Fee Due

$

-

(1)	These ordinary shares are represented by ADSs, each of which represents six ordinary shares of the registrant. ADSs issuable on deposit of the ordinary shares registered hereby have been registered pursuant to a separate registration statement on Form F-6 (File No. 333-235561).
(2)	Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the registrant’s ADSs on the Nasdaq Capital Market on August 19, 2022, of $1.24.